Skip to main content
. 2019 May 10;19(Suppl 3):474. doi: 10.1186/s12889-019-6780-7

Table 1.

Descriptive statistics of Shigella cases stratified by healthcare facility in Santa Rosa and Quetzaltenango Departments, Guatemala 2007–2012

All Cases
N (%)a
261 (100)
Hospital
N (%)a
30 (100)
Ambulatory
N (%)a
231 (100)
P-value
Demographics
Sex
  Female 149 (57.1) 14 (46.7) 135 (58.4) 0.22
Age
  0 to 6 months 2 (0.8) 1 (3.3) 1 (0.4) 0.001
  6 months to < 1 year 16 (6.1) 5 (16.7) 11 (4.8)
  1 to 4 years 133 (50.9) 19 (63.2) 114 (49.5)
  5 to 9 years 36 (13.8) 1 (3.3) 35 (15.2)
  10 to 20 years 29 (11.1) 0 (0.0) 29 (12.6)
  20 to 40 years 25 (9.6) 0 (0.0) 25 (10.8)
  40 to 60 years 9 (3.5) 0 (0.0) 9 (3.9)
  60 + years 11 (4.2) 4 (13.3) 7 (3.0)
Symptoms
Under 5 years 151 (100.0) 23 (100.0) 128 (100.0)
 Vomiting 42 (28.0) 17 (74.0) 25 (37.8) < 0.0001
 Unable to drink or breastfeed 71 (47.0) 15 (60.0) 56 (44.1) 0.15
 Convulsions 5 (4.0) 3 (13.0) 2 (2.2) 0.024
 Lethargy 57 (36.0) 3 (12.0) 54 (40.0) 0.007
All ages
 Temperature in oC Median (Range) 37 (34.4–40) 37 (36–39.5) 36.9 (34.4–40)
 Vomiting 99 (38.1) 21 (70.0) 78 (33.9) < 0.0001
 Abdominal Pain 185 (71.2) 11 (37.0) 174 (75.7) < 0.0001
 Bloody stool 80 (30.8) 5 (17.0) 75 (32.6) 0.19
 Mucoid stool 183 (70.4) 15 (50.0) 168 (73.0) 0.009
 Co-Infections
  Campylobacter coli 2 (0.8) 0 (0.0) 2 (0.9) 0.61
  Campylobacter jejuni 4 (1.5) 0 (0.0) 4 (1.7) 0.47
  Rotavirus 3 (1.3) 3 (10.0) 0 (0.0) < 0.0001
  Any protozoa or helminth 78 (30.0) 6 (20.0) 72 (31.6) 0.19
  Giardia 5 (1.9) 0 (0.0) 5 (2.2) 0.41
Treatmentb
Oral rehydration salts or solution 37 (25.0) 18 (72.0) 19 (15.0) < 0.0001

aProportions based on non-missing data

bNot sufficient antibiotic data for treatment. 18 patients had other treatment, 4 had antibiotics and 9 had salts/solution